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Aim: A pre-operative nomogram using a population-based database to predict peri-operative mortality
risk after liver resections for malignancy has recently been developed. The aim of the present study was
to perform an external validation of the nomogram using data from a high volume institution.
Methods: The National Inpatient Sample (NIS) database (2000–2004) was used initially to construct the
nomogram. The dataset for external validation was obtained from a high volume centre specializing in
hepatobiliary surgery. Validation was performed using calibration plots and concordance index.
Results: A total of 794 patients who underwent liver resection from the years 2000–2010 at the external
institute were included in the validation set with an observed mortality rate of 1.6%. The mean total points
for this sample of patients was 124.9 [standard error (SE) 1.8, range 0–383] which translates to a
nomogram predicted mortality rate of 1.5%, similar to the actual observed overall mortality rate. The
nomogram concordance index was 0.65 [95% confidence interval (CI) 0.46–0.82] and calibration plots
stratified by quartiles revealed good agreement between the predicted and observed mortality rates.
Conclusions: The present study provides an external validation of the pre-operative nomogram to
predict the risk of peri-operative mortality after liver resection for malignancy.
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Introduction
Hepatic resection is a well-accepted modality in the treatment
algorithm of patients with primary and secondary malignancies
involving the liver. Several previous studies have demonstrated
that the number of hepatic resections being performed for
malignancy have significantly increased over the past decade.1,2
In spite of the increasing number of procedures being per-
formed, hepatic resections are major operations that are associ-
ated with significant morbidity and mortality.2–4 The majority of
these operations are also performed in middle-aged to elderly
individuals who have multiple pre-existing co-morbidities. The
pre-operative counselling to discuss and determine the likely rate
of peri-operative mortality associated with these high-risk
procedures remains an important part of the management
algorithm.
Several recent studies have proposed different tools to predict
peri-operative outcomes after hepatic resections.5–10 A nomo-
gram was recently devised by our institute using easily available
pre-operative variables to enable prediction of peri-operative
mortality after hepatic resections for malignancy.11 This nomo-
gram was constructed from data derived from a national data-
base comprising heterogenous institutions and low to high
volume surgeons. It is not clear whether predictive tools devel-
oped from this database are reliable and accurate when applied
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to specific centres. The aim of the present study was, therefore,
to undertake an external validation of a population-based
dataset derived nomogram predicting mortality after liver resec-
tion for malignancy by utilizing data derived from a high
volume single academic centre.
Methods
The National Inpatient Sample(NIS) database (2000–2004) was
initially used to develop the nomogram which included age,
race, gender, liver primary, coagulopathy, renal failure, congestive
heart failure (CHF), cardiac arrhythmias and other major
co-morbidities (Fig. 1).11 The dataset for external validation was
obtained from the University of Pittsburgh Liver Cancer Centre.
Data were obtained from a prospectively maintained dataset of
all patients undergoing liver resections for malignancy at this
institute. Peri-operative mortality for both datasets was defined
as the mortality during the same hospital admission.
Statistical methods
SAS software (SAS Institute Inc., Cary, NC, USA) was used for
all statistical analysis. The nomogram was initially constructed
using the previously described techniques, using the NIS dataset
from 2000 to 2004.12,13 Each variable was assigned points based
the multivariate logistic regression. Depending on the number of
variables/factors present in the case of an individual patient, the
total number of points was calculated for each person in the NIS
2000 to 2004 dataset. The median total points for this dataset
were 116 with a range of 0 to 469 which corresponds to a mor-
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Figure 1 Representative figure of the nomgram (published with permission from Springerlink. Originally published in Dhir et al. J Gastrointest
Surg 2010)11. CHF, Congestive heart failure; COPD, Chronic obstructive pulmonary disease; Unk, Unknown
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tality rate of 1.3%.11 The overall observed mortality rate in this
(NIS 2000–2004) dataset was 4.1%.11
The distribution of patient characteristics in the external vali-
dation dataset was compared with the populate values estimated
from the NIS dataset using one sample tests for proportions,
using a two-sided exact test. Validation was performed using
data derived from the external institute utilizing calibration plots
and concordance index. Briefly, the concordance index was cal-
culated by comparing the patients who died to those who were
alive. All possible pairs were constructed between dead and alive
patients. For each pair, if the nomogram assigned a higher prob-
ability of death to the patient who died compared with the ones
alive, then the model matched the data and the pair was said to
be concordant. The concordance index is the probability of
being concordant out of all possible dead/alive patient pairs. A
95% confidence interval (CI) was calculated for the concordance
index based on 10 000 bootstrapped samples. A calibration plot
was constructed by plotting predicted probabilities from the
nomogram versus the actual probabilities. Quartiles of the pre-
dicted probabilities were delineated and observed mortality pro-
portions were determined for the quartiles along with 95% CIs,
and plotted. A perfectly predictive nomogram should result in
the observed and expected probabilities aligned along a 45
degree line.
Results
A total of 795 patients underwent liver resections for malignancy
from 2000–2010. One person was excluded from the analysis as
data on in-hospital mortality were not available. Median age for
all patients was 65 years [standard deviation (SD) 12.5, range
18–92]. Approximately half (445/794, 56%) of the patients were
males and the median length of stay was 6 days (range 0–39). The
distributions of the relevant variables are summarized in Table 1.
There were significant differences between the two datasets i.e. the
NIS dataset and the external validation dataset with regards to
demographic variables, diagnoses, procedure types and various
co-morbidities. Briefly, the patients operated at the University of
Pittsburgh Medical Centre (UPMC) (external validation dataset)
were older, had shorter lengths of hospital stay, had larger volume
resections and more often underwent resections for primary
hepatobiliary malignancies.
The nomogram was validated using the external validation
dataset. The median total points for the external validation
dataset were 115 with a range of 0 to 383. The median total
points in this dataset correspond to a predicted mortality rate of
1.2%. The overall observed mortality rate in the external valida-
tion dataset was 1.6% (13/794). The concordance index calcu-
lated with the external validation dataset was found to be 0.65
(95% CI 0.46–0.82).
Calibration of the nomogram was tested using the observed
mortality and the model predicted mortality. First, the quartiles of
the predicted probabilities for patients who died in the external
dataset were determined (Table 2). The observed mortality rates
were calculated for the predicted probability deciles along with
95% CIs and plotted against the predicted probabilities (Fig. 2).
The 45 degree line on the plot shows an imaginary line depicting
perfect agreement between the observed probabilities and the
nomogram predicted probabilities. The observed probabilities
closely approximate the 45 degree imaginary line depicting pre-
dicted probability and therefore shows a good agreement.
Discussion
Hepatic resection still remains one of the main options available
to patients with malignancies of the liver.1,2 Over the past decade
the number of hepatic resections have been increasing in number
owing to the expanding criteria for resectability as well as increas-
ing the number of treatment strategies available for the treatment
of primary and secondary malignancies of the liver.1,2,14–20 Simi-
larly, the number of complex resections as well as the number of
resections being performed in elderly individuals with significant
co-morbidities has been increasing.2–4 Being major procedures
these operations are often fraught with significant morbidity and
mortality.2–4 Therefore, discussion of peri-operative mortality
remains an important part of thorough pre-operative patient
counselling and informed consent.
In spite of the increasing number of resections being per-
formed, the reported peri-operative mortality rates remain highly
variable in the published literature.2,3,21–26 Variability in the pub-
lished mortality rates make the discussion of patient-specific peri-
operative mortality difficult at the time of informed consent and
often leave the individual patients uncertain about their mortality
rates. In order to overcome these limitations several authors have
attempted to devise prediction tools such as risk scores and nomo-
grams to predict peri-operative outcomes for patients undergoing
hepatic resections.5,7–10,27 Although risk score systems are useful, it
is thought that nomograms are superior to risk scores or risk
grouping systems in predicting probabilities tailored to an indi-
vidual patient.28,29 Additionally, most of the tools devised to
predict peri-operative outcomes lack an external validation which
limits their wide clinical use.8–10,27 Recently, a pre-operative nomo-
gram to predict patient-specific peri-operative mortality after
hepatic resections for malignancy has been constructed.11 The
present study was undertaken to perform an external validation of
this pre-operative nomogram to testify its applicability in a dif-
ferent clinical setting.
The current nomogram was designed using a nationwide
population-based dataset NIS, which is heterogeneous in nature
comprising of patients treated at different hospitals including
rural vs. urban hospitals, small to medium vs. large hospitals,
teaching vs. non-teaching hospitals, etc. However, for the purpose
of validation, the dataset on the other end of spectrum i.e. high
volume, single institute, centre of excellence was chosen, to test the
robustness of the nomogram in a distinctly dissimilar setting.
These factors may have contributed to the significant differences
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in the demographic factors, diagnoses and procedure types and
various tested co-morbidities as shown in Table 1. Peri-operative
mortality in the NIS dataset was found to be 4.1% which is similar
to mortality in other population-based datasets as previously
reported.21 This mortality was almost two and half times the mor-
tality reported in an external validation set which is representative
of mortality at high volume centres. In spite of these differences,
the nomogram shows a good agreement between the observed
and predicted probabilities between the two datasets with a mod-
erate concordance index.
One major criticism of the tools derived from population-
based administrative datasets is their limited applicability to high
Table 1 Comparison of demographic characteristics, diagnoses, procedure types and co-morbidities between the National Inpatient Sample
(NIS) (years 2000–2004) dataset and the external validation dataset
NIS (years 2000–2004) dataset External validation dataset P-value
Weighted frequency Percentage Frequency Percentage
Age 70 or less 14731 75.8 545 68.6 <0.001
Over 70 4692 24.2 249 31.4
Length of stay 10 days or less 15992 82.3 690 87.1 <0.001
More than 10 days 3431 17.7 102 12.9
Race Non-white 3444 17.7 42 5.3 <0.001
Unknown 4210 21.7 4 0.5
White 11769 60.6 748 94.2
Admission type Elective 15198 78.2 770 97.0 <0.001
Emergency/urgent 1713 8.8 23 2.9
Unknown 2512 12.9 1 0.1
Gender Male 10884 56.1 445 56.1 1.0
Female 8529 43.9 349 43.9
Liver procedures Lobectomy or
(wedge + lobectomy)
8836 45.5 412 51.9 <0.001
Wedge only 10587 54.5 382 48.1
Liver primary No 13410 69.0 640 80.6 <0.001
Yes 6013 31.0 154 19.4
CHF No 18927 97.4 774 97.5 1.0
Yes 495 2.6 20 2.5
Cardiac arrhythmia No 17851 91.9 745 93.8 0.047
Yes 1572 8.1 49 6.2
Hypertension No 12655 65.2 600 75.6 <0.001
Yes 6768 34.8 194 24.4
Other Neurological
Disorders
No 19263 99.2 786 99.0 0.610
Yes 160 0.8 8 1.0
COPD No 17902 92.2 723 91.1 0.260
Yes 1521 7.8 71 8.9
Renal failure No 19280 99.3 779 98.1 0.001
Yes 142 0.7 15 1.9
Liver disease No 16452 84.7 708 89.2 <0.001
Yes 2971 15.3 86 10.8
Coagulopathy No 18347 94.5 773 97.4 <0.001
Yes 1076 5.5 21 2.6
Fluid and electrolyte
disorders
No 16876 86.9 726 91.4 <0.001
Yes 2546 13.1 68 8.6
Inpatient death No 18606 95.9 781 98.4 <0.001
Yes 802 4.1 13 1.6
CHF, Congestive heart failure; COPD, Chronic obstructive pulmonary disease.
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volume centres which have significantly lower mortality when
compared with population-based mortality rates.21 Previous
studies have internally validated the nomogram using a validation
set from a different year from the same NIS dataset (year 2005).11
The present study further upholds the applicability of the nomo-
gram to data derived from high volume single centres. In spite of
these strengths there are several limitations to the present study.
Drawing the estimates from a more heterogeneous population
may add to their generalizability but may yield estimates with a
higher degree of error for each patient.8 The concordance index
observed in the current study showed only a moderate agreement
and there may be under and over estimation of mortality for
certain subgroups of patients. Although the calibration plots for
the validation set looked good the CIs were wide. These could be
as a result of extremely small number of deaths (thirteen) in the
external validation dataset. Again, this underscores the fact that
the nomogram is meant to be used as an additional tool and is not
meant to replace the surgeons assessment based on adequate clini-
cal parameters. Some of the other limitations and strengths of our
nomogram have been discussed previously.11
In conclusion, the present study validates the use of the nomo-
gram in the setting of a single high volume institute. The current
nomogram is a simple tool which is patient specific, is available in
the pre-operative setting and is applicable to both primary and
secondary liver malignancies. The ease of use of this nomogram
will make it an adjunctive clinical tool in the pre-operative setting
and combined with good clinical judgment make it useful for
patient counselling, obtaining informed consent and optimizing
peri-operative care. To the authors’ knowledge, this nomogram
may be the only clinical tool which has been externally validated to
predict the pre-operative mortality after liver resections for malig-
nancy. The validation of this nomogram in both the population-
based setting11 and currently in a single institute setting makes it
potentially applicable in broader and wider clinical settings.
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